BIG
RXRX icon

Brooklyn Investment Group’s Recursion Pharmaceuticals RXRX Stock Holding History

Brooklyn Investment Group’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-274
Closed -$1.39K – 2267
2025
Q2 		$1.39K Buy
+274
New +$1.35K ﹤0.01% 2848
2025
Q1 		– Sell
-724
Closed -$4.89K – 2870
2024
Q4 		$4.89K Buy
+724
New +$4.87K ﹤0.01% 1216

Other funds holding RXRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brooklyn Investment Group's RXRX Position: Q3 2025 in Review

Brooklyn Investment Group sold out of Recursion Pharmaceuticals (RXRX) in Q3 2025, closing a stake of 274 shares — an estimated $1.39K sold.

Brooklyn Investment Group first reported a position in RXRX in Q4 2024 and held it in 2 quarters. The position peaked at $4.89K in Q4 2024. 322 funds tracked by Wall St. Rank hold RXRX as of Q3 2025.

  • Brooklyn Investment Group reported no remaining Recursion Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 274 Recursion Pharmaceuticals shares in Q3 2025, an estimated $1.39K.
  • Brooklyn Investment Group first reported a position in Recursion Pharmaceuticals in Q4 2024 and held it in 2 quarters.
  • Brooklyn Investment Group's Recursion Pharmaceuticals position peaked at $4.89K in Q4 2024.
  • 322 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2025.

Based on Brooklyn Investment Group's 13F filing for Q3 2025, filed 14 Nov 2025.